Valuation: Sera Prognostics, Inc.

Market Cap 80.87M 72.58M 67.02M 60.77M 114M 7.68B 115M 804M 319M 4.03B 304M 297M 12.77B P/E 2026 *
-3.12x
P/E 2027 * -3.83x
Enterprise Value 80.87M 72.58M 67.02M 60.77M 114M 7.68B 115M 804M 319M 4.03B 304M 297M 12.77B EV / Sales 2026 *
359x
EV / Sales 2027 * 42x
Free-Float
85.73%
Yield 2026 *
-
Yield 2027 * -
1 day+0.49%
1 week+0.99%
Current month-1.91%
1 month+0.49%
6 months+2.50%
Current year-30.51%
1 week 2.03
Extreme 2.03
2.1
1 month 2
Extreme 2
2.21
Current year 1.56
Extreme 1.56
3.85
1 year 1.56
Extreme 1.56
3.85
3 years 1.37
Extreme 1.37
12.36
5 years 1.1
Extreme 1.1
12.36
10 years 1.1
Extreme 1.1
15.5
Manager TitleAgeSince
Chief Executive Officer 52 31/05/2023
Director of Finance/CFO 47 30/08/2026
Chief Tech/Sci/R&D Officer - 31/12/2021
Director TitleAgeSince
Chairman 74 19/04/2011
Chairman 58 07/06/2023
Director/Board Member 59 31/10/2011
Date Insider Type Main position Quantity % Market Cap. Importance
12/10/26 Sell

Chief Technology Officer

-8,024 0.0209%
10/09/26 Sell

Chief Executive Officer

-7,022 0.0182%
10/09/26 Sell

General Counsel

-2,190 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+0.49%+0.99%-45.19%+22.75% 80.48M
-0.57%-1.16%+15.54%+75.28% 742B
-4.93%-1.03%+13.84%+73.08% 89.71B
+3.57%+11.32%+29.06%+191.21% 69.46B
+2.00%-1.84%-20.16%+11.31% 47.04B
+0.43%-4.14%-6.59%+87.08% 45.07B
+11.22%-0.57%+35.91%+800.05% 42.01B
+3.07%+6.29%+16.09%+42.80% 32.54B
-0.68%-2.78%+39.68%+78.92% 26.25B
-1.92%-1.76%-62.54%-57.85% 25.7B
Average +1.24%+0.53%+1.56%+132.46% 111.97B
Weighted average by Cap. -0.10%-0.34%+13.40%+103.36%

Financials

2026 *2027 *
Net sales 225K 202K 186K 169K 316K 21.37M 320K 2.24M 888K 11.2M 845K 827K 35.52M 1.92M 1.73M 1.6M 1.45M 2.7M 183M 2.74M 19.13M 7.6M 95.84M 7.23M 7.07M 304M
Net income -33.93M -30.46M -28.12M -25.5M -47.66M -3.22B -48.25M -337M -134M -1.69B -127M -125M -5.36B -29.1M -26.12M -24.12M -21.87M -40.87M -2.76B -41.37M -289M -115M -1.45B -109M -107M -4.59B
Net Debt - -
Projected Income Statement - Annual - Sera Prognostics, Inc.
Logo Sera Prognostics, Inc.
Sera Prognostics, Inc. is a women's health diagnostic company utilizing its proprietary proteomics and bioinformatics platform, and significant data resources to enhance maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are accurate predictors of dynamic changes that occur during pregnancy. Its commercial product, the PreTRM test, is a validated, commercially available blood-based biomarker test to predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation that provides a prediction of the expectant mother’s risk of delivering spontaneously before 37 weeks’ gestation.
Employees
72
Date Price Change Volume
27/10/26 US$2.050 +0.49% 13,568
26/10/26 US$2.040 +0.49% 25,415
23/10/26 US$2.030 -0.49% 25,030
22/10/26 US$2.040 +0.49% 31,223
21/10/26 US$2.030 0.00% 24,224
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Sera Prognostics, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.050USD
Average target price
5.500USD
Spread / Average Target
+168.29%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Sera Prognostics, Inc.
  1. Stock Market
  2. Stocks
  3. SERA Stock